About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Monday, July 30th, 2012

The QualityStocks
Daily Stock List


Dynetek Industries Ltd. (DNK.TO)

We are highlighting Dynetek Industries Ltd. (DNK.TO) today, here at the QualityStocks Daily Newsletter.

Listed on the Toronto Stock Exchange, Dynetek Industries Ltd. is a leading participant in the global clean technology space. The Company is also a leader in the design and manufacture of proprietary fuel storage systems. Dynetek, and their 100 percent owned subsidiary Dynetek Europe GmbH, manufacture and develop the world's leading alternative energy fuel storage cylinders and systems. Dynetek Industries has their corporate headquarters in Calgary, Alberta. Dynetek Europe has their office in Ratingen, Germany.

Dynetek designs, produces and markets one of the lightest and most advanced fuel storage and refueling systems for compressed natural gas, low emission vehicles and compressed hydrogen, zero-emission fuel cell vehicles. The Company has recognition worldwide for their solutions-of-choice to the alternate fuel vehicle sector. This is evidenced by their strategic relationships with major manufacturers globally. Dynetek has products performing in the critical markets of Asia, North America, South America, Europe and the Middle East.

The Company is a world leader in stationary fueling station infrastructure. They were the first company to sell compressed hydrogen storage on a commercial basis and developed the first certified 5000psi (350bar) cylinder. Dynetek was the first to demonstrate a Mobile Hydrogen Refueling System and they successfully tested the world's first 12500psi (825bar) lightweight cylinder. In addition, the Company developed the first composite cylinder to receive Transport Canada (TC) and Department of Transport (DOT) approval to haul bulk quantities of compressed gas.

Dynetek designs and manufactures complete fuel systems. The core technology of Dynetek fuel systems is the DyneCell® cylinder, which is one of the fastest filling cylinders on the market. The DyneCell lightweight composite cylinder is built from a seamless 'thin wall' aluminum liner with a full carbon fiber overwrap. This ultra-lightweight liner technology guarantees higher storage capacity. The Company’s natural gas and hydrogen storage products sell around the world to major automotive, commercial and transit manufacturers.

Recently, Dynetek Industries announced that the Toronto Stock Exchange (the TSX) approved the Company's request to hold their 2012 Annual General Meeting on or before September 17, 2012.

Dynetek Industries Ltd. (DNK.TO), closed Monday’s trading session at $0.15, up 15.38%, on 203,100 volume. The 52-week low/high is $0.06/$0.34.

Somaxon Pharmaceuticals, Inc. (SOMX)

OTCPicks and PennyTrader Publisher reported recently on Somaxon Pharmaceuticals, Inc. (SOMX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Founded and incorporated in 2003, Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company with corporate headquarters in San Diego, California. The Company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and/or high level of patient dissatisfaction. Currently, Somaxon is focusing on the central nervous system therapeutic area. The Company’s shares trade on the NASDAQ Capital Market.

The Company has their Silenor® (doxepin) product. Silenor® is an oral tablet formulation of doxepin. It is available by prescription in the United States. Silenor® is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Silenor® can be used to treat people with chronic sleep maintenance insomnia (insomnia lasting more than three weeks). It can also be used to treat people with transient insomnia (short term).

Silenor® is not a controlled substance. It has no abuse potential or evidence of physical dependence/withdrawal symptoms. Patients in clinical trials reported a low rate of side effects; drowsiness or tiredness was the most common side effect. Somaxon offers Silenor® in 3 mg and 6 mg tablets. Somaxon sells their product primarily to wholesale distributors in the pharmaceutical industry in the United States.

Last week, Somaxon Pharmaceuticals announced that they completed their previously announced registered direct offering of approximately 9.4 million shares of their common stock and warrants to purchase up to approximately 4.7 million shares of their common stock to institutional investors. Aggregate gross proceeds to Somaxon were approximately $3.0 million. The warrants will have an initial exercise price of $0.46 per share, will be exercisable commencing six months and one day from the date of issuance and will expire on the fifth anniversary of the initial exercise date. Roth Capital Partners acted as sole placement agent for the offering.

Somaxon Pharmaceuticals, Inc. (SOMX), closed Monday’s trading session at $0.36, up 1.10%, on 2,082,127 volume with 989 trades. The average volume for the last 60 days is 706,333. The 52-week low/high is $0.25/$1.66.

Turbine Truck Engines, Inc. (TTEG)

MoneyTV reported recently on Turbine Truck Engines, Inc. (TTEG), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

Turbine Truck Engines, Inc. is an American technology company that lists on the OTC Bulletin Board. The Company focuses on continuing the development, manufacture, and global distribution of their energy efficient and environmentally-friendly products. Turbine Truck Engines’ corporate mission is to provide the trucking industry with a cutting edge, new, energy efficient engine technology. The Company has their headquarters in Paisley, Florida.

Turbine Truck Engines is the exclusive agent for Hydrogen Union Energy Co. Ltd.'s (HUE) hydrogen generation technology throughout all of North America. HUE is a subsidiary of Taiwan Energy Technology Services Co., Ltd. (ETS). Using a gas reformation process employing a proprietary chemical catalyst and a unique low temperature pyrolytic reaction, HUE's generator converts common methanol into clean-burning hydrogen gas for immediate on-site use. The process removes all harmful emissions except for food grade carbon dioxide. The food grade carbon dioxide can be captured and sold to the food and beverage industry as part of the Carbon Credit Asset Program.

Turbine Truck Engines owns an exclusive worldwide license for the manufacturing and marketing of a highly innovative, low emissions turbine-based truck engine known as the Detonation Cycle Gas Turbine (DCGT) engine. The DCGT engine features patented cyclic detonation technology. The DCGT technology is scalable. The DCGT engine has no pistons or valves; and uses no lube oil, filters or pumps. It uses more than 30 percent less fuel than current engine technologies.

The DCGT engine significantly reduces nitrogen oxide (NO, NO2, N2O2) and carbon monoxide (CO) emissions. It operates on all fuels (hydrocarbon, hydrogen and synthetic) and has flex-fuel and mixed fuels capability. In addition, it has few moving parts. Therefore, it requires less maintenance. The DCGT engine has a high power-to-weight ratio; it is lightweight (less than 2 lbs. per hp); it is air cooled, and has cold start capability. Turbine Truck Engines continues to work on DCGT development with their partners in the United States and internationally.

Turbine Truck Engines, Inc. (TTEG), closed Monday at $0.05, even with yesterday’s close. The average volume for the last 60 days is 90,914. The 52-week low/high is $0.02/$0.23.

IntelGenx Technologies Corp. (IGX.V)

We are highlighting IntelGenx Technologies Corp. (IGX.V), here at the QualityStocks Daily Newsletter.

IntelGenx Technologies Corp. is a drug delivery company with corporate headquarters in Ville St-Laurent, Quebec. The Company focuses on the development of oral controlled-release products and novel rapidly disintegrating delivery systems. Their business strategy is to apply their proprietary drug delivery technologies to improve existing drug compounds with proven efficacy and safety and, in conjunction with strategic development and distribution partners, reintroduce these drug compounds to the market as branded products with improved deliverability and efficacy. IntelGenx Technologies’ shares trade on the TSX Venture Exchange.

IntelGenx Technologies’ common stock began trading on the prestigious OTCQX® U.S. trading platform with effect from June 14, 2012. The OTCQX® is the highest tier of the OTC market; it is exclusively for companies that meet the highest financial standards and undergo a qualitative review. IntelGenx Technologies' trading symbol on this platform is IGXT.

The design of the Company’s three technology platforms have been to address the challenges commonly encountered in oral drug delivery, such as first-pass metabolism, gastrointestinal side effects, or incomplete absorption of the drug in the gastrointestinal (GI)  tract. IntelGenx’ current technology portfolio includes a Multilayer Tablet and Oral Drug Delivery Systems.

IntelGenx uses their unique multiple layer delivery system to provide zero-order release of active drugs in the GI tract. Additionally, the Company has developed novel delivery technologies for the rapid delivery of pharmaceutically active substances in the oral cavity based on their experience with rapidly disintegrating films. IntelGenx' research and development pipeline includes products for the treatment of severe depression, hypertension, erectile dysfunction, benign prostatic hyperplasia, migraine, insomnia, bipolar disorder, idiopathic pulmonary fibrosis, allergies and pain management.

In late May 2012, IntelGenx Technologies announced the completion of the pivotal bioequivalence study for a novel oral thin-film formulation of Rizatriptan, the active drug in Maxalt-MLT® orally disintegrating tablets. Maxalt-MLT® is a leading branded anti-migraine product manufactured by Merck & Co. The thin-film formulation of Rizatriptan has been developed using IntelGenx' proprietary immediate release "VersaFilm" drug delivery technology. The Company’s immediate release oral film Technology, VersaFilm, is made up of a strip of thin polymeric film comprised of United States Pharmacopeia (USP) components that are safe and approved by the FDA for use in food, pharmaceutical and cosmetic products.

IntelGenx Technologies Corp. (IGX.V), closed Monday’s session at $0.60, even with yesterday’s close, on 1,500 volume. The 52-week low/high is $0.41/$0.77.

Pervasip Corp. (PVSP)

GoldmanStockReport, AwesomePennyPicks, AwesomePennyStocks, and Manny Smith reported this month on Pervasip Corp. (PVSP), Penny Stock Rumble, SmallCapVoice, and Stock Legends did earlier, and we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Listed on the OTC Markets, Pervasip Corp. provides voice and video telephone services, products, and hosted solutions in the U.S and globally. The Company provides IP telephone services primarily to broadband service providers and other telephone service providers. Pervasip markets voice and messaging services under the brand name of VoX Communications. Pervasip has their headquarters in White Plains, New York.
The Company offers wholesale voice over Internet protocol (VoIP) telephone services and customized private label Internet protocol (IP) telephony service, as well as a back-office and Web suite of services for the residential and small business markets. In addition, Pervasip resells analog telephone adapters, mobile phones, and IP videophones.

Pervasip’s VoX Communications subsidiary is a technology based company that has developed a very flexible, stable and scalable Linux based server cluster that is virtualized in "The Cloud". VoX Communications delivers voice and video anywhere globally where a stable broadband connection exists. Their technology is highly adaptive and has been architected to undergo modification quickly and easily to react to the ever changing communications market demands.

VoX was founded in 2004 to evolve the legacy telecom resale business that their parent company ELEC (which later became Pervasip) operated, into an owned and operated all IP network that was capable of millions of subscribers. This year VoX developed their Android Mobile VoIP application and uploaded it to the Android Market. VoX Communications is a cloud-based voice and video communications solutions, apps and services provider.

This month, Pervasip subsidiary, VoX Communications, announced that they are partnering with G3 South Africa to facilitate the sales of hardware and apps on the continent of Africa. VoX’s intention is to package their network capabilities with innovative hardware to build a diverse global business.

Last week, Pervasip reported Second Quarter Earnings of $1.2 million. They had a quarterly Gross Margin of 47 percent compared to 39 percent in the prior year. The Company had quarterly Earnings of $0.01 per share basic; $0.01 per share diluted. They had monthly Sales growth in June of 9 percent over the month of May and their Mobile VoIP app sales continue to grow in July.

Pervasip Corp. (PVSP), closed Monday’s trading session at $0.01, down 13.33%, on 671,510 volume with 15 trades. The average volume for the last 60 days is 770,163. The 52-week low/high is $0.005/$0.05.

NeurogesX, Inc. (NGSX)

We are highlighting NeurogesX, Inc. (NGSX), here at the QualityStocks Daily Newsletter.

NeurogesX, Inc. is a specialty pharmaceutical company based in San Mateo, California. The Company’s focus is on developing and commercializing a portfolio of novel non-opioid, pain management therapies to address unmet medical needs and improve patients' quality of life. Their lead product, Qutenza®, is currently approved in the United States and the European Union. NeurogesX lists on the OTC Bulletin Board.

The Company’s Qutenza® is now available in the U.S. for the management of neuropathic pain associated with postherpetic neuralgia (PHN). In Europe, Qutenza® is being marketed by Astellas Pharma Europe Ltd., the European affiliate of Tokyo-based Astellas Pharma, Inc. It is being marketed for the treatment of peripheral neuropathic pain in non-diabetic adults, either alone or in combination with other medicinal products for pain.

NeurogesX’ most advanced product candidate is NGX-1998. This product candidate is a topically applied liquid formulation containing a high concentration of capsaicin designed to treat pain associated with neuropathic pain conditions such as PHN. NGX-1998 has completed three Phase 1 clinical trials and one Phase 2 clinical trial in PHN patients. NeurogesX believes that NGX-1998 is ready to enter Phase 3 development.

Moreover, the Company’s early-stage pipeline includes pre-clinical compounds. These include several prodrugs of acetaminophen. NeurogesX has evaluated certain of these compounds in vitro and in vivo.

Last Tuesday, NeurogesX announced that their partner, Astellas Pharma Europe, enrolled the first patient in their ELEVATE clinical trial in the European Union (EU). This trial is the first study to compare Qutenza® (8% capsaicin patch) to pregabalin as a treatment for peripheral neuropathic pain. Under their Commercial License Agreement with Astellas, NeurogesX shares in the growing market opportunity for Qutenza® in the Astellas territory, which includes the EU, the Middle East and Africa, through ongoing royalties and potential sales milestones.

In addition, last Friday, NeurogesX announced that they will hold a conference call on Friday, August 3, 2012, at 8:30 a.m. ET (5:30 a.m. PT) to report results for the Company’s second quarter ended June 30, 2012. Mr. Ronald Martell, President and Chief Executive Officer, Mr. Stephen Ghiglieri, Executive Vice President, Chief Operating Officer and Chief Financial Officer, and Dr. Stephen Peroutka, Executive Vice President and Chief Medical Officer will host the conference call.

NeurogesX, Inc. (NGSX), closed Monday’s trading at $0.24, up 6.82%, on 17,400 volume with 7 trades. The average volume for the last 60 days is 28,476. The 52-week low/high is $0.18/$0.35.

Single Touch Systems, Inc. (SITO)

Today we are reporting on Single Touch Systems, Inc. (SITO), here at the QualityStocks Daily Newsletter.

Single Touch Systems, Inc. is a technology based mobile media solutions provider that lists on the OTC Bulletin Board. The Company enables businesses, advertisers and brands to easily connect with customers by way of their patented technologies. Through patented technologies and a modular, adaptable platform, Single Touch’s multi-channel messaging gateway enables marketers to reach consumers on all types of connected devices, with information that engages interest, drives transactions and strengthens relationships and loyalty. Single Touch Systems is based in Encinitas, California.

The Company is focusing in three key areas. One is Reminder Messaging; users can create and manage all their text messaging campaigns from one interface. A second area is Abbreviated Dial Code (ADC). This involves an easy to remember, short phone number to call with a natural voice interface to download content to mobile devices, driving brand advertising and promotions. Mobile Dial Codes (ADC/MDC)‏ are being used as a handset based data distribution channel. Single Touch is known for developing the Abbreviated Dial Code (ADC) market with notable brands like MTV and BET.

The third area is an Advertising and Coupon Platform. This enables mass market penetration and awareness to provide discounts, coupons, and loyalty programs. It provides promotions and metrics in relevancy to the consumer, real transactions, and superior customer engagement. The Mobile Digital Coupon solution ties the coupon/discount to a mobile phone number.

Recently, Single Touch Interactive, Inc., a wholly owned subsidiary of Single Touch Systems, announced that they signed a licensing agreement for their proprietary Abbreviated Dial Code technology, with Mobile Direct Response (MDR), a digital marketing and advertising firm. Under the agreement, Single Touch will license their Abbreviated Dial Code technology on a non-exclusive basis to MDR, powering their mobile marketing and advertising campaigns.

Last Thursday, Single Touch Interactive announced that a settlement conference has been scheduled in the Company’s Patent infringement lawsuit against Zoove Corp. The settlement conference is scheduled for August 27, 2012. Single Touch’s complaint filed against Zoove in the United States District Court in the Northern District of California on February 22, 2012 alleges Patent infringement, in which Single Touch seeks preliminary and permanent injunctive relief as well as damages resulting from Zoove’s infringement of their U.S. Patents.

Single Touch Systems, Inc. (SITO), closed Monday’s trading at $0.25, up 11.36%, on 167,370 volume with 27 trades. The average volume for the last 60 days is 37,087. The 52-week low/high is $0.15/$0.54.

GeoGlobal Resources, Inc. (GGR)

SmarTrend Newsletters reported earlier on GeoGlobal Resources, Inc. (GGR), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

GeoGlobal Resources, Inc. is an oil and gas company headquartered in Calgary, Alberta. The Company, through their subsidiaries, engages in the pursuit of petroleum and natural gas in high potential exploration targets through exploration and development in India, Israel and Colombia. GeoGlobal initiated their activities in India in 2003. The Company’s mission is to be recognized as a worldwide leader in the exploration of conventional oil and gas. 

GeoGlobal Resources holds a well balanced portfolio of assets with production of both natural gas and crude oil in India. Their inaugural step into the oil and gas industry was the participation in the signing of a Production Sharing Contract on the KG-OSN-2001/3 Offshore Block in India in 2004. Since that time, the Company has continued to grow their asset position with the participation in 9 additional production sharing contracts in India, 3 licenses in Israel and 2 licenses in Colombia. GeoGlobal Resources operates 5 of their 15 blocks/licenses, 2 of which are in India and 3 of which are in Israel. Their 15 blocks/licenses encompass approximately 3.7 million gross acres (1.6 million net acres) of land and so far 99 wells have been drilled on those blocks/licenses.

Last week, GeoGlobal Resources announced updates for their exploration blocks RJ-20 and RJ-21. On June 22, 2012, drilling operations were completed on the Punam-1 well located within the Exploration Block RJ-20. The well is currently undergoing testing based on positive indications of oil-bearing formations within the targeted Bilara-Jodhpur reservoirs. Drilling of the Punam-1 well started on May 7, 2012 and was drilled to a vertical depth of 1,297 meters to test the Bilara-Jodhpur reservoirs.

Concerning RJ-21, on July 20, 2012, on behalf of the Government of India, the Directorate General of Hydrocarbons invoked their performance bank guarantee of US$897,500 for the period April 1, 2011 to September 30, 2012 on account of Oil India Ltd., as Operator on behalf of the consortium's decision not to complete the minimum work program for exploration block RJ-21.

The performance bank guarantee was in the form of an irrevocable letter of credit for which Export Development Canada (EDC) provided the performance security guarantee on behalf of GeoGlobal Resources; the Company has agreed to fully indemnify EDC against all claims and demands made in respect of this performance bank guarantee. GeoGlobal Resources is currently negotiating payment terms with EDC.

Mr. Paul B. Miller, President and CEO of GeoGlobal Resources, said, ""We remain optimistic with what the Punam-1 well tests have yielded, and the potential implications they have for our exploratory program on the RJ-20 Block as a whole. We are disappointed by the DGH's decision to not allow us to continue with the work program in the RJ-21 Block and in turn to call the performance bank guarantee for not completing the minimum work program. However, with the discovery in RJ-20, we hope to move forward with the exploratory program for Block RJ-20 and will apply for the appropriate extensions as required."

GeoGlobal Resources, Inc. (GGR), closed Monday’s trading session at $0.24, down 0.17%, on 141,035 volume with 89 trades. The average volume for the last 60 days is 173,999. The 52-week low/high is $0.18/$0.48.


The QualityStocks
Company Corner


International Stem Cell Corp. (ISCO)

The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $0.32, up 6.31%, on 93,310 volume with 27 trades. The stock’s average daily volume over the past 60 days is 5,767, and its 52-week low/high is $0.21/$1.00.

International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. The company was first to perfect the natural phenomenon of parthenogenesis, which utilizes unfertilized human eggs to create hpSCs. These stem cells, created in a particular form called HLA homozygous, can be immune-matched to millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.

hpSCs are as pluripotent as embryonic stem cells (ESCs) and have significant therapeutic potential but their creation does not involve the destruction of a viable human embryo – thus sidestepping the controversy and ethical dilemmas associated with the use of human embryonic stem cells. Different from induced pluripotent stem cells (iPSs), hpSCs do not involve manipulation of gene expression back to a less differentiated stage – a practice that may become a safety or regulatory obstacle in clinical applications.

A relatively small number of hpSC lines can offer the potential of producing the first true stem cell bank, UniStemCell, which ISCO intends to create as a means of serving populations across the globe. The company's scientists are currently focused on using hpSC to treat severe diseases of the eye, nervous system, and liver, for which cell therapy has been clinically proven but is limited due to the unavailability of safe human cells.

In addition to its therapeutic focus, ISCO also provides two revenue streams. Firstly through its subsidiary Lifeline Cell Technology, specialized cells and growth media for biological research around the world, and secondly its subsidiary Lifeline Skin Care, the company manufactures and sells anti-aging skincare products utilizing an extract from the hpSC and by leveraging the latest discoveries in the fields of stem cell biology, nanotechnology, and skin cream formulation technology. Disclaimer

International Stem Cell Corp. Company Blog

International Stem Cell Corp. News:

International Stem Cell Corporation's Co-Chairman and CEO Andrey Semechkin PhD Publishes Letter to Shareholders

International Stem Cell Corporation Featured in Stem Cell Technology's Bright Future Article on Seeking Alpha

International Stem Cell Corporation Reports Reaching Milestone in Its Cornea Program

Duma Energy Corp. (DUMA)

The QualityStocks Daily Newsletter would like to spotlight Duma Energy Corp. (DUMA). Today, Duma Energy Corp. closed trading at $1.62, even with yesterday's close, on 15,300 volume with 11 trades. The stock’s average daily volume over the past 60 days is 5,894, and its 52-week low/high is $1.10/$4.00.

Duma Energy Corp. (DUMA) is an aggressive growth company actively producing oil and gas in the domestic United States, both on and offshore. Leveraging its technical expertise, promising portfolio, and strong financial condition, the company plans to utilize domestic revenues and cash flow to fund its rapid growth through acquisition, while participating in transformational projects with the potential of providing exponential returns for shareholders.

The company's primary goal for fiscal year 2012 and beyond is to drive earnings growth. The company also aims to pursue listing on major exchange(s) to provide better visibility and liquidity to shareholders and financial partners. Already producing and generating revenue from oil and gas in Texas, Illinois, and Louisiana, Duma projects domestic production to exceed 1,000 barrels of oil equivalent per day (boepd) by the end of 2012; with 2,500 boepd projected by the end of 2013.

Duma was founded in 2005 and began trading on the OTCBB in 2009 via registration. In 2006, the company began producing from its first properties in Texas and soon after added production in Louisiana. In 2009, its new CEO Jeremy G. Driver came on board. Within one year, Mr. Driver had identified and negotiated an acquisition that would fundamentally reshape the company. This acquisition was made possible by the large direct cash investment by Mr. Driver and his family, as well as other investors.

The company uses only industry standard and time-tested technologies, and avoids unproven "resource plays" and other opportunities that are heavily dependent upon high commodity prices. Not bound by any geographical location or operational strategy, Duma's management team is focused on developing its existing portfolio while pursuing additional opportunities that provide rapid growth, leveraging growing revenue, cash flow, and reserves to accelerate its growth strategy. Disclaimer

Duma Energy Corp. Company Blog

Duma Energy Corp. News:

Duma Energy Enters Final Stage of Negotiations for African Concession

Duma Energy Provides Third Quarter Results and Demonstrates Positive Earnings

Duma Energy Announces New Trading Symbol "DUMA"

Skinny Nutritional Corp. (SKNY)

The QualityStocks Daily Newsletter would like to spotlight Skinny Nutritional Corp. (SKNY). Today, Skinny Nutritional Corp. closed trading at $0.01, off by 1.59%, on 1,376,610 volume with 41 trades. The stock’s average daily volume over the past 60 days is 2,691,808, and its 52-week low/high is $0.0052/$0.068.

Skinny Nutritional Corp. (SKNY) has established their Skinny Water® brand as a clear alternative to other products in the enhanced water space, with the only true zero calorie, sugar, carb, sodium, and preservative-containing beverage available. Skinny Water's proprietary formulation of essential antioxidant agents, electrolytes, and the critical vitamins our bodies need in order to achieve optimal function, uses 100% natural flavors, no preservatives, no artificial colors, and only the best purified water.

The company has constructed a network of approximately 50 domestic distributors (with three more internationally), placing product on shelves approximately 15k stores across the United States. Derived from the natural flavors contained in fruits, Skinny Water represents a fortified, extremely low-impact, great-tasting array of beverages that provide a concentrated punch of the nutrients essential for a healthier lifestyle.

The company's strong emphasis on health, fitness, and community has served marketing initiatives very well. The new age beverage segment has seen increasing momentum in recent years, with just about every beverage company getting into the game, but none of them has the kind of no-nonsense product composition behind Skinny Water, something that appeals directly to the majority of the core consumer market.

Skinny Nutritional continues to build value around the Skinny Water brand, and today has numerous trademarks in the healthy beverage and snack food categories. As consumers migrate away from sugar based beverages and empty calories, Skinny Water is ideally positioned to benefit from positive market trends as management focuses on delivering exceptional value to shareholders. Disclaimer

Skinny Nutritional Corp. Blog

Skinny Nutritional Corp. News:

A&P's 275 Stores Continue Skinny Water's Mid-Atlantic Penetration

Skinny Nutritional Corp. Enters Into $15M Financing, Positions Company to Grow Skinny Brand Portfolio Nationally

Skinny Nutritional Corp. Enters Distribution Agreement With Michigan-Based D&B Grocers Wholesale, Inc.

GlobalWise Investments, Inc. (GWIV)

The QualityStocks Daily Newsletter would like to spotlight GlobalWise Investments, Inc. (GWIV). Today, GlobalWise Investments, Inc. closed trading at $1.66, off by 1.78%, on 1,800 volume with 2 trades. The stock’s average daily volume over the past 60 days is 3,611, and its 52-week low/high is $1.02/$1.87.

GlobalWise Investments, Inc. (GWIV), via wholly-owned subsidiary Intellinetics, Inc., is a leading-edge technology company focused on Enterprise Content Management (ECM) solutions for the digital age. The ECM industry continues to grow rapidly as a result of unrestricted proliferation of digital content within today's business environment. Leveraging its proprietary cloud-based computing software, GlobalWise is poised to capture a significant market share of this burgeoning industry.

GlobalWise's ECM service is delivered to customers via five unique delivery models which cover the spectrum of business needs: Cloud/Saas (Software as a Service), Hardware Vendor Integrated Service, Software Vendor Integrated Service, Premise (Client-Server), Hybrid (Premise & Cloud/Saas).This diversity gives advanced security & privacy features with an on-demand structure needed for large Tier 3 and Tier 4 businesses that are currently underserved by the market.

The Intellinetics platform defines a new industry benchmark and game-changing approach by combining advanced virtualization & automated content management with an open and service-oriented architecture using web services. The company provides strategies, tactics, and technologies used to manage paper and digital assets from capture to long-term archive, without the need for manual processes conducted by a full time employee.

GlobalWise's management boasts a combined total of over 60 years in ECM leadership and industry experience. The ECM industry is expected to exceed $5.1 billion by 2013 with Gartner predicting a compound annual growth rate of 9.5%. IBM Market Insights predicts adoption of cloud computing to grow by 26% CAGR between 2010 through 2013. Leveraging management and key department heads, Intellinetics has a strong foundation from which to capture significant market share within the lucrative $149 billion Business Software & Services industry. Disclaimer

GlobalWise Investments Company Blog

GlobalWise Investments News:

GlobalWise Accepted as Member of Prestigious Organization Technology United

GlobalWise CEO to Be Featured Speaker at World Expo 2012 Conference

GlobalWise ECM Software Intellivue™ Named #1 at Prestigious Managed Printer Conference by "The Week in Imaging"

Facts and Advantages Behind Duma Energy Corp. (DUMA)

Duma Energy is a growing energy company, based in Houston, Texas, with oil and gas interests in Texas, Louisiana, and Illinois. The story of the company’s past and future growth potential is perhaps best seen in the numbers and strategic advantages the company possesses.

• The company produced 38,000 barrels of oil equivalent (boe) in fiscal 2011, and has already produced over 45,000 boe in the first half of fiscal 2012.

• Duma lists $77 million in proven resources (with less than $12 million as booked reserves).

• Most recent year-over-year revenue growth exceeds 500%.

• 75% of the invested capital comes directly from the CEO and insiders. Of the 10.7 million shares outstanding, 5.9 million are held by the CEO and insiders.

• Duma’s strategy focuses on ROI, not just barrels of oil.

• The company is set up so as not to be limited by any geographical location or operational strategy.

• Duma’s highly experienced team targets only industry standard and time-tested technologies, preferring to learn from the mistakes of others. They avoid unproven resource plays that depend upon high commodity prices, thereby minimizing investor risk.

• The company’s current interests are in Galveston Bay and Trinity Bay, Texas, as well as Duval, Victoria, and Karnes County, Texas, with additional interests in Jefferson County, Illinois, and Franklin Parish, Louisiana. The company is also pursuing acquisition of a private company with significant interests in an African concession totaling approximately 6 million acres.

• The company’s growth plan involves continued acquisitions, including possible international opportunities with high return potential, with the goal of leveraging growing revenue, cash flow, and reserves to fund ongoing expansion.

• Careful and experience-based management has allowed Duma to reduce debt to zero, continually grow revenue and assets, and establish a positive operational cash flow. All major metrics show positive improvement and momentum.

• Operating margins, now near 50%, are improving as new wells and production increase efficiencies.

• Numbers anticipated for the end of calendar 2012 include production of 1,000 boe per day gross, positive cash flow and earnings, and approval for listing on a major exchange. By the end of 2013, production is planned to be 2,500 boe per day.

For additional information, visit the company’s website at www.DUMA.com

Skinny Nutritional Corp. (SKNY) Offers Skinny Water for Every Purpose

The value of customization is well known as a major factor in customer appeal. It offers a link to the consumer that more generic offerings cannot. Customization doesn’t have to mean sitting down with every person to determine individual preferences, but rather simply recognizing the range of market needs and opportunities in a given class of products. It’s the reason that there are different models of cars and many choices of ice cream.

Skinny Nutritional makes effective use of this principle in its Skinny Water line of health beverages. The company has managed to develop multiple offerings, each of which is formulated to meet specific health needs.

• Lemonade Passion Fruit (Total-V)

Vitamins B3, B5, B6, B12 + C (energy, mental clarity and whole body vitality)
Vitamin A (essential for the eyes, as well as skin and immune system replenishment)
Vitamin E (boosts red blood cell and muscle development)
Magnesium + Folic Acid (helps absorb calcium for bone health and energy production)
Calcium (builds strong skeletal system)
Potassium (helps maintain cellular hydration)

• Orange Cranberry Tangerine (Wake Up)

Vitamin C (powerful antioxidant, boosts immunity; good for skin, teeth, bones blood vessels)
Vitamin A (promotes vision health)
Vitamin E (Vitamin A regulator, neutralizes free radicals, maintains healthy-looking skin and hair)
Calcium (builds strong skeletal system)
Potassium (helps maintain cellular hydration)

• Raspberry Pomegranate (Crave Control)

SuperCitriMax® (a patented form of an herbal extract rich in hydroxycitrix acid (HCA), naturally derived from the Garcinia Cambogia fruit native to parts of Asia and known for its appetite suppressing qualities, with each 1,500 mg SuperCitriMax® serving providing 900 mg of HCA)
Calcium (builds strong skeletal system)
Potassium (aids in the regulation of the body’s water balance, helps the body hydrate and replenish)

• Sport Goji Black Cherry (Shape)

Vitamins: A, E, B3, B5, B6
Calcium (mineral/electrolyte, promotes strong, healthy bones & teeth, muscles, nervous system)
Magnesium (mineral/electrolyte, activates metabolic enzymes and are critical for energy generation)
Potassium (mineral/electrolyte, blood regulator and stabilizer, helps heart, brain, kidney, muscles)

• Acai Grape Blueberry (Hi-Energy)

Acai Extract (contains powerful antioxidants)
Guarana (natural caffeine stimulates metabolism)
Ginseng (combats fatigue and stimulate metabolism)
Vitamins B3, B6 & B12 (energy, metabolism, skin, muscle tone, helps immune and nervous system)
Calcium (builds strong skeletal system)
Potassium (helps maintain cellular hydration)

• Sport Sport Blue Raspberry (Fit)

Vitamins: B3, B5, B6
Calcium (mineral/electrolyte, promotes healthy bones & teeth, muscles, nerves)
Magnesium (mineral/electrolyte, activates metabolic enzymes, energy generation)
Potassium (mineral/electrolyte, blood regulator, healthy heart, brain, kidney, muscle, water balance)

• Sport Pink Berry Citrus (Power)

Vitamins: A, E, B3, B5, B6
Calcium (mineral/electrolyte, promotes healthy bones & teeth, muscles, nerves)
Magnesium (mineral/electrolyte, activates metabolic enzymes and are critical for energy generation)
Potassium (mineral/electrolyte, blood regulator, healthy heart, brain, kidney, muscle, water balance)

• Sport Kiwi Lime (Active)

Vitamins: B3, B5, B6, C
Calcium (mineral/electrolyte, promotes healthy bones & teeth, muscles, nerves)
Magnesium (mineral/electrolyte, activates metabolic enzymes, energy generation)
Potassium (mineral/electrolyte, blood regulator, healthy heart, brain, kidney, muscle, water balance)

For additional information, visit the company’s websites atwww.SkinnyWater.com

CytoSorbents Corp. (CTSO) and Its Breakthrough Medical Technology

CytoSorbents is a New Jersey based healthcare company that has developed a therapeutic device for blood purification, applicable to kidney disease, sepsis, and other life threatening diseases. CytoSorb™, the company’s flagship product, uses what is called hemoperfusion technology, involving the passing of blood over adsorbent substances outside of the body to remove toxins. The specially designed adsorbent material in this case consists of biocompatible, highly porous polymer beads, each containing millions of pores and channels that can be modified to remove substances as small as drugs and as large as antibodies. The system is designed to remove excessive cytokines in critically-ill patients that can lead to deadly inflammation, multiple organ failure, immune dysfunction, and often death in common illnesses such as sepsis, trauma, burn injury, acute respiratory distress syndrome, and pancreatitis.

By addressing one of the most challenging and unmet medical needs, the ability to prevent or mitigate multiple organ failure, which is the leading cause of death in hospital intensive care units, CytoSorb® is a potentially breakthrough therapy. In response to life-threatening conditions such as sepsis and infection, trauma, serious burn injuries, severe lung injury, and pancreatitis, the body frequently overreacts, producing a massive excess of cytokines. Cytokines normally help the body cope with injury, but at these levels they are toxic, creating what is called “cytokine storm,” driving severe inflammation and a cascade of pathophysiologic changes in the body that cause cell damage, organ failure, and often death. Until recently, there were no effective ways to reduce cytokine storm broadly. This is what is addressed by CytoSorb.

In March 2011, CytoSorb™, the company’s flagship product, achieved European regulatory approval as an extracorporeal cytokine filter, and can now be sold throughout the European Union (E.U.) under the CE Mark to be used in clinical situations where cytokines are elevated.

In addition, the company has a development-stage blood purification technology platform called HemoDefend, designed for the blood transfusion industry and intended to reduce transfusion reactions and safeguard the quality and safety of blood products. CytoSorb™ and HemoDefend are just two of a number of different resins that CytoSorbents has designed for various medical applications, including improved dialysis, the potential treatment of inflammatory and autoimmune disorders, rhabdomyolysis in trauma, removal of chemotherapy drugs during treatment of cancer with high dose regional chemotherapy, drug detoxification, and others.

For additional information, visit the company’s websites atwww.CytoSorbents.com

GelTech Solutions, Inc. (GLTC) is “One to Watch”

GelTech Solutions is a company on the forefront of water additive materials science with cutting-edge, environmentally friendly products, like their nontoxic FireIce®, firefighting/protectant gel, and the revolutionary soil remediation/dust suppression conditioner, Soil2O™.

FireIce is a paradigm-shattering firefighting tool that not only bypasses any need for the environmentally harmful chemicals (stabilizers and surfactants among others) typically found in alternatives, but actually binds water molecules together, forming a fire protectant shield. This gel shield snuffs out the flame, denying oxygen access to the flammable surface with a nice thick coating, while simultaneously dropping the temperature of the heat source rapidly. Cheaper and easier to use than the competition, with a squeaky-clean environmental profile, FireIce can be easily stored until ready to use.

You may have seen the creator of FireIce, Peter Cordani, on television/online, going at his own hand with a 2,000 degree blowtorch, confident that the FireIce gel coating his hand completely protects him from injury. This incredibly powerful substance has seen great success fighting wildfires in New Mexico recently and the US Forest Service’s tactical approach to fighting the nation’s wildfires was called into question by John Stossel on his show on FOX Business Network, for failure to comprehensively adopt FireIce (despite having approved its use on the ground and in the air), as the product is widely accepted to be the most effective fire suppressant/retardant on the market today.

The company has even packaged the product into a simple kit targeted at the homeowner. The FireIce Home Defense Unit™ brings the same protection from temperatures as high as 2k degrees Fahrenheit that is available to fire departments, Single Engine Airtanker pilots fighting the large wildfires in the southwestern United States, and the company’s network of GelTech Solution Distributors (mostly firefighting equipment suppliers), to the homeowner. An easy to use, portable, and high powered sprayer, together with two buckets (1,250 sq. ft each of wall/roof coverage) of FireIce, can safeguard a structure for up to 24 hours.

The same material engineering brilliance that produced FireIce also led to GelTech’s other major offering, Soil2O™, a natural polymer used for saving huge amounts of water (typically halves water/irrigation requirements) on lawn care, in backyard gardening, and in agricultural production. Infusing the soil and allowing for retention of as much as 400 times the polymer’s weight in water (keeping it where it needs to be and releasing 95% of that water back to the root mass on plant demand), Soil2O uses the same water molecule binding properties found in FireIce to also create optimal soil cohesion. Soil2O helps eliminate runoff and can be spread for controlling dust on construction sites, on road work, in fields, and anywhere else dust is a hazard.

The company recently reported signing a massive, 10-year exclusive distribution agreement valued at some $87.9M (minimum purchase level of $6M in year one) with XingFang Group Ltd. to sell FireIce in the PRC, giving GLTC a huge window to the larger Asian marketplace as well.

For more information on GelTech Solutions, Inc., please visit the company’s website at: www.GelTechSolutions.com


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters








By The Numbers Charts

Featured Sponsor

Daily Sponsors

The QualityStocks By The Numbers Report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251